COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,043 Articles (22,627 medRxiv, 8,416 bioRxiv)

Most recent first Previous |  Page 116: Articles 1151-1160  | Next

Clinical impact and cost-effectiveness of updated 2023/24 COVID-19 mRNA vaccination in high-risk populations in the United States
Joshi, K., Dronova, M., Paterak, E., Nguyen, V. H., Kopel, H., Mansi, J., Van de Velde, N., Beck, E.
10.1101/2024.11.15.24317369 — Posted: 2024-11-15
Human ace2 and tmprss2 polymorphisms for predicting susceptibility to tuberculosis and COVID-19 co-infection in Cameroonian cohort.
Kameni, M. N., Tchoupe, E. B., Kamdem, S. D., Bhalla, N., Paul, A. A. J., Arnaud, T. N., Neba, F. R., Nanda, R. K., Awuah, A. A.-A., Amuasi, J., Masumbe Netongo, P. M.
10.1101/2024.11.14.24317326 — Posted: 2024-11-15
Immunogenicity and safety of DS-5670d, an mRNA-based COVID-19 vaccine targeting omicron XBB.1.5: Results from a phase 3, randomized, active-controlled study in adults and children aged >=12 years
Takeshita, F., Kawamoto, A., Hashida, M., Ishida, K., Furihata, K., Ota, A., Takahashi, K., Sakakibara, S., Nakano, T.
10.1101/2024.11.14.24317321 — Posted: 2024-11-15
Examining Brain Structures and Cognitive Functions in Patients with Recovered COVID-19 Infection: A Multicenter Study Using 7T MRI
Liou, J.-J., Santini, T., Li, J., Gireud-Goss, M., Patel, V., Adeyemi, O., de Erausquin, G. A., Garbarino, V., Habes, M., Himali, J. J., Karmonik, C., Snitz, B., Mettenburg, J., Wu, M., Aizenstein, H., Marsland, A., Gianaros, P., Bowtell, R., Mougin, O., Vahidy, F. S., Girard, T., I.L. Jacobs, H., Hosseini, A. A., Seshadri, S., Ibrahim, T. S.
10.1101/2024.11.13.24317121 — Posted: 2024-11-15
Long-Term Coronary Microvascular and Cardiac Dysfunction Following Severe COVID-19 Hospitalization
Steffen Johansson, R., Loewenstein, D., Lodin, K., Bruchfeld, J., Runold, M., Stahlberg, M., Xue, H., Kellman, P., Caidahl, K., Engblom, H., Nickander, J.
10.1101/2024.11.14.24317343 — Posted: 2024-11-15
Risk Communication and Public Health Emergency Responses during COVID - 19 Pandemic in Rural Communities in Kenya: A Cross-sectional Study
Cholo, W., Njororai, F., Amulla, W. O., Nyaranga, C. K.
10.1101/2024.11.15.24317380 — Posted: 2024-11-15
Characteristics of early career health researchers and experiences of burnout during the COVID-19 pandemic in Canada
Hewko, S., Kowalec, K., Anderson, L., Mulvihill, E. E., Aristizabal, M., Ciernia, A. V., Dhillon, S., Dufour, A., Lim, G. E., Rousseaux, M., Saleem, A., Daraz, L., Lam, G., Association of Canadian Early Career Health Researchers
10.1101/2024.11.13.622718 — Posted: 2024-11-14
Manipulation of Host Cholesterol by SARS-CoV-2
Doyle, A., Goodson, B. A., Kolaczkowski, O. M., Liu, R., Jia, J., Wang, H., Han, X., Ye, C., Bradfute, S. B., Kell, A. M., Rosas Lemus, M., Pu, J.
10.1101/2024.11.13.623299 — Posted: 2024-11-14
Modeling the SARS-CoV-2 Epidemic and the Efficacy of Different Vaccines Across Different Network Structures
Hartvigsen, G., Dimitroff, Y.
10.1101/2024.11.12.24317192 — Posted: 2024-11-13
Descriptive epidemiology of COVID-19 outcomes in England, from September 2023 to April 2024
Abdul Aziz, N., Allen, H., Assaraf, K., Dabrera, G., Ramsay, M., Allen, A.
10.1101/2024.11.12.24317146 — Posted: 2024-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).